liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
BETA
Nilsson, Staffan
Publications (10 of 29) Show all publications
Karlsson, L., Nilsson, S., Bång, M., Nilsson, L., Charitakis, E. & Janzon, M. (2018). A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study). PLoS Medicine, 15(3), Article ID e1002528.
Open this publication in new window or tab >>A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study)
Show others...
2018 (English)In: PLoS Medicine, ISSN 1549-1277, E-ISSN 1549-1676, Vol. 15, no 3, article id e1002528Article in journal (Refereed) Published
Abstract [en]

Background

Atrial fibrillation (AF) is associated with substantial morbidity, in particular stroke. Despite good evidence for the reduction of stroke risk with anticoagulant therapy, there remains significant undertreatment. The main aim of the current study was to investigate whether a clinical decision support tool (CDS) for stroke prevention integrated in the electronic health record could improve adherence to guidelines for stroke prevention in patients with AF.

Methods and findings

We conducted a cluster-randomized trial where all 43 primary care clinics in the county of Östergötland, Sweden (population 444,347), were randomized to be part of the CDS intervention or to serve as controls. The CDS produced an alert for physicians responsible for patients with AF and at increased risk for thromboembolism (according to the CHA2DS2-VASc algorithm) without anticoagulant therapy. The primary endpoint was adherence to guidelines after 1 year. After randomization, there were 22 and 21 primary care clinics in the CDS and control groups, respectively. There were no significant differences in baseline adherence to guidelines regarding anticoagulant therapy between the 2 groups (CDS group 70.3% [5,186/7,370; 95% CI 62.9%–77.7%], control group 70.0% [4,187/6,009; 95% CI 60.4%–79.6%], p = 0.83). After 12 months, analysis with linear regression with adjustment for primary care clinic size and adherence to guidelines at baseline revealed a significant increase in guideline adherence in the CDS (73.0%, 95% CI 64.6%–81.4%) versus the control group (71.2%, 95% CI 60.8%–81.6%, p = 0.013, with a treatment effect estimate of 0.016 [95% CI 0.003–0.028]; number of patients with AF included in the final analysis 8,292 and 6,508 in the CDS and control group, respectively). Over the study period, there was no difference in the incidence of stroke, transient ischemic attack, or systemic thromboembolism in the CDS group versus the control group (49 [95% CI 43–55] per 1,000 patients with AF in the CDS group compared to 47 [95% CI 39–55] per 1,000 patients with AF in the control group, p = 0.64). Regarding safety, the CDS group had a lower incidence of significant bleeding, with events in 12 (95% CI 9–15) per 1,000 patients with AF compared to 16 (95% CI 12–20) per 1,000 patients with AF in the control group (p = 0.04). Limitations of the study design include that the analysis was carried out in a catchment area with a high baseline adherence rate, and issues regarding reproducibility to other regions.

Conclusions

The present study demonstrates that a CDS can increase guideline adherence for anticoagulant therapy in patients with AF. Even though the observed difference was small, this is the first randomized study to our knowledge indicating beneficial effects with a CDS in patients with AF.

Place, publisher, year, edition, pages
San Francisco, United States: Public Library of Science, 2018
National Category
General Practice
Identifiers
urn:nbn:se:liu:diva-147426 (URN)10.1371/journal.pmed.1002528 (DOI)000428983600016 ()29534063 (PubMedID)2-s2.0-85045620091 (Scopus ID)
Note

Funding Agencies|ALF grants, Region Ostergotland [LIO 608011]

Available from: 2018-05-17 Created: 2018-05-17 Last updated: 2019-05-01Bibliographically approved
Andersson, P., Sederholm Lawesson, S., Karlsson, J.-E., Nilsson, S. & Thylén, I. (2018). Characteristics of patients with acute myocardial infarction contacting primary healthcare before hospitalisation: a cross-sectional study. BMC Family Practice, 19, Article ID 167.
Open this publication in new window or tab >>Characteristics of patients with acute myocardial infarction contacting primary healthcare before hospitalisation: a cross-sectional study
Show others...
2018 (English)In: BMC Family Practice, ISSN 1471-2296, E-ISSN 1471-2296, Vol. 19, article id 167Article in journal (Refereed) Published
Abstract [en]

Background: The characteristics of patients with on-going myocardial infarction (MI) contacting the primary healthcare (PHC) centre before hospitalisation are not well known. Prompt diagnosis is crucial in patients with MI, but many patients delay seeking medical care. The aims of this study was to 1) describe background characteristics, symptoms, actions and delay times in patients contacting the PHC before hospitalisation when falling ill with an acute MI, 2) compare those patients with acute MI patients not contacting the PHC, and 3) explore factors associated with a PHC contact in acute MI patients. Methods: This was a cross-sectional multicentre study, enrolling consecutive patients with MI within 24 hours of admission to hospital from Nov 2012 until Feb 2014. Results: A total of 688 patients with MI, 519 men and 169 women, were included; the mean age was 66 +/- 11 years. One in five people contacted PHC instead of the recommended emergency medical services (EMS), and 94% of these patients experienced cardinal symptoms of an acute MI; i.e., chest pain, and/or radiating pain in the arms, and/or cold sweat. Median delay time from symptom-onset-to-decision-to-seek-care was 2:15 hours in PHC patients and 0:40 hours in non-PHC patients (pamp;lt;0.01). The probability of utilising the PHC before hospitalisation was associated with fluctuating symptoms (OR 1.74), pain intensity (OR 0.90) symptoms during off-hours (OR 0.42), study hospital (OR 3.49 and 2.52, respectively, for two of the county hospitals) and a final STEMI diagnosis (OR 0.58). Conclusions: Ambulance services are still underutilized in acute MI patients. A substantial part of the patients contacts their primary healthcare centre before they are diagnosed with MI, although experiencing cardinal symptoms such as chest pain. There is need for better knowledge in the population about symptoms of MI and adequate pathways to qualified care. Knowledge and awareness amongst primary healthcare professionals on the occurrence of MI patients is imperative.

Place, publisher, year, edition, pages
BMC, 2018
Keywords
Chest pain; Myocardial infarction; Primary healthcare; Pre-hospital delay
National Category
General Practice
Identifiers
urn:nbn:se:liu:diva-152382 (URN)10.1186/s12875-018-0849-8 (DOI)000447149900001 ()30305077 (PubMedID)
Note

Funding Agencies|Medical Research Council of Southeast Sweden (FORSS); Region Ostergotland, ALF

Available from: 2018-10-30 Created: 2018-10-30 Last updated: 2019-05-02
Kärner Köhler, A., Tingström, P., Jaarsma, T. & Nilsson, S. (2018). Patient empowerment and general self-efficacy in patients with coronary heart disease: a cross-sectional study. BMC Family Practice, 19, Article ID 76.
Open this publication in new window or tab >>Patient empowerment and general self-efficacy in patients with coronary heart disease: a cross-sectional study
2018 (English)In: BMC Family Practice, ISSN 1471-2296, E-ISSN 1471-2296, Vol. 19, article id 76Article in journal (Refereed) Published
Abstract [en]

Background

In managing a life with coronary heart disease and the possibility of planning and following a rehabilitation plan, patients’ empowerment and self-efficacy are considered important. However, currently there is limited data on levels of empowerment among patients with coronary heart disease, and demographic and clinical characteristics associated with patient empowerment are not known.

The purpose of this study was to assess the level of patient empowerment and general self-efficacy in patients six to 12 months after the cardiac event. We also aimed to explore the relationship between patient empowerment, general self-efficacy and other related factors such as quality of life and demographic variables.

Methods

A sample of 157 cardiac patients (78% male; age 68 ± 8.5 years) was recruited from a Swedish hospital. Patient empowerment was assessed using the SWE-CES-10. Additional data was collected on general self-efficacy and well-being (EQ5D and Ladder of Life). Demographic and clinical variables were collected from medical records and interviews.

Results

The mean levels of patient empowerment and general self-efficacy on a 0–4 scale were 3.69 (±0.54) and 3.13 (±0.52) respectively, and the relationship between patient empowerment and general self-efficacy was weak (r = 0.38). In a simple linear regression, patient empowerment and general self-efficacy were significantly correlated with marital status, current self-rated health and future well-being. Multiple linear regressions on patient empowerment (Model 1) and general self-efficacy (Model 2) showed an independent significant association between patient empowerment and current self-rated health. General self-efficacy was not independently associated with any of the variables.

Conclusions

Patients with a diagnosis of coronary heart disease reported high levels of empowerment and general self-efficacy at six to 12 months after the event. Clinical and demographic variables were not independently associated with empowerment or low general self-efficacy. Patient empowerment and general self-efficacy were not mutually interchangeable, and therefore both need to be measured when planning for secondary prevention in primary health care.

Place, publisher, year, edition, pages
BioMed Central, 2018
Keywords
Patient empowerment, General self-efficacy, Coronary heart disease, Self-rated health, Well-being, Primary health care
National Category
Other Health Sciences Cardiac and Cardiovascular Systems General Practice
Identifiers
urn:nbn:se:liu:diva-148478 (URN)10.1186/s12875-018-0749-y (DOI)000434076700001 ()
Funder
The Swedish Heart and Lung Association, E091/10, E122/11, E083/12, E103/13
Note

Funding agencies: Swedish Heart and Lung Association [E091/10, E122/11, E083/12, E103/13]; County Council/Region Ostergotland, Sweden [LIO-92281, LIO-125151, LIO-27535, LIO-354951, LIO-433801]

Available from: 2018-06-12 Created: 2018-06-12 Last updated: 2019-10-23Bibliographically approved
Wennerholm, C., Bromley, C., Johansson, A., Nilsson, S., Frank, J. & Faresjö, T. (2017). Two tales of cardiovascular risks-middle-aged women living in Sweden and Scotland: a cross-sectional comparative study. BMJ Open, 7(8), Article ID e016527.
Open this publication in new window or tab >>Two tales of cardiovascular risks-middle-aged women living in Sweden and Scotland: a cross-sectional comparative study
Show others...
2017 (English)In: BMJ Open, ISSN 2044-6055, E-ISSN 2044-6055, Vol. 7, no 8, article id e016527Article in journal (Refereed) Published
Abstract [en]

OBJECTIVES: To compare cardiovascular risk factors as well as rates of cardiovascular diseases in middle-aged women from urban areas in Scotland and Sweden.

DESIGN: Comparative cross-sectional study.

SETTING: Data from the general population in urban areas of Scotland and the general population in two major Swedish cities in southeast Sweden, south of Stockholm.

PARTICIPANTS: Comparable data of middle-aged women (40-65 years) from the Scottish Health Survey (n=6250) and the Swedish QWIN study (n=741) were merged together into a new dataset (n=6991 participants).

MAIN OUTCOME MEASURE: We compared middle-aged women in urban areas in Sweden and Scotland regarding risk factors for cardiovascular disease (CVD), CVD diagnosis, anthropometrics, psychological distress and lifestyle.

RESULTS: In almost all measurements, there were significant differences between the countries, favouring the Swedish women. Scottish women demonstrated a higher frequency of alcohol consumption, smoking, obesity, low vegetable consumption, a sedentary lifestyle and also more psychological distress. For doctor-diagnosed coronary heart disease, there were also significant differences, with a higher prevalence among the Scottish women.

CONCLUSIONS: This is one of the first studies that clearly shows that Scottish middle-aged women are particularly affected by a worse profile of CVD risks. The profound differences in CVD risk and outcome frequency in the two populations are likely to have arisen from differences in the two groups of women's social, cultural, political and economic environments.

Place, publisher, year, edition, pages
London: BMJ Publishing Group Ltd, 2017
Keywords
cardiovascular risk factors, comparative study, lifestyle, middle-aged women, psychological distress, public health
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
urn:nbn:se:liu:diva-140935 (URN)10.1136/bmjopen-2017-016527 (DOI)000411802700172 ()28790040 (PubMedID)2-s2.0-85027162863 (Scopus ID)
Note

Funding agencies: Swedish Heart and Lung Association [E136-15/E106/13]; Clinic ALF funds, Region Ostergotland, Sweden [LiO-446241]; Research and PhD studies Committee (FUN), Linkoping University, Sweden [LiU-2014-020251]

Available from: 2017-09-18 Created: 2017-09-18 Last updated: 2018-05-03Bibliographically approved
Milovanovic, M., Nilsson, S., Harakka, P., Post, C. & Gerlde, B. (2016). High in vivo platelet activity in female fibromyalgia patients. Journal of Biomedical Sciences, 5(3:21), 1-5
Open this publication in new window or tab >>High in vivo platelet activity in female fibromyalgia patients
Show others...
2016 (English)In: Journal of Biomedical Sciences, ISSN 2254-609X, Vol. 5, no 3:21, p. 1-5Article in journal (Refereed) Published
Abstract [en]

Introduction: Fibromyalgia (FMS) is a pain syndrome characterized by chronic widespread pain and hyperalgesia/allodynia. Many affected are women and risk factors are unidentified. Today, a certain number of set criteria of disease signs and symptoms must be met for the diagnosis to be made. These criteria are used because of the lack of reliable biomarkers or other medical examination. The current study examines if in vivo platelet activity varies between FMS and controls without FMS.

Material and Methods: The study involves 24 females (age 38 + 9 (SD) years) with diagnosed FMS. 25 healthy females (age 50 + 12 (SD) years) without FMS served as controls. After sampling the whole platelet population was separated according to density with a linear Percoll™, into 17 density fractions. Platelet counts was carried out in all fractions using a routine cell counter. In addition, a flow cytometer was used to measure platelet bound fibrinogen without platelet agonist, reflecting in vivo platelet activity.

Results: The study groups did not differ with respect to the distribution of platelets in the gradient. FMS sufferers demonstrated a significant higher platelet bound fibrinogen in most of the platelet density fractions. In particular, significant differences (p < 0.05) were obtained in fractions numbers 2-14 and 16. In difference, fractions numbers 1, 15 and 17 did not show any significant variance.

Discussion: This is the first study to examine in vivo platelet activity in FMS. The results indicate that FMS is associated with elevated in vivo platelet activity compared to individuals without FMS. The clinical significance and the biochemical mechanisms regarding platelet heterogeneity are still uncertain. The results stimulate further research to elucidate the importance of platelet diversity in FMS

Place, publisher, year, edition, pages
iMedPub, 2016
Keywords
Fibromyalgia; Fibrinogen; Platelets; Platelet activity; Platelet heterogeneity
National Category
Obstetrics, Gynecology and Reproductive Medicine
Identifiers
urn:nbn:se:liu:diva-130641 (URN)10.4172/2254-609X.100035 (DOI)
Available from: 2016-08-19 Created: 2016-08-19 Last updated: 2018-03-20
Andersson, P., Karlsson, J.-E., Landberg, E., Festin, K. & Nilsson, S. (2015). Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study. BMC Research Notes, 8(1), 1-9
Open this publication in new window or tab >>Consequences of high-sensitivity troponin T testing applied in a primary care population with chest pain compared with a commercially available point-of-care troponin T analysis: an observational prospective study
Show others...
2015 (English)In: BMC Research Notes, ISSN 1756-0500, E-ISSN 1756-0500, Vol. 8, no 1, p. 1-9Article in journal (Refereed) Published
Abstract [en]

BACKGROUND:There is a demand for a highly sensitive and specific point-of care test to detect acute myocardial infarction (AMI). It is unclear if a high-sensitivity troponin assay will have enough discriminative power to become a decision support in primary care. The aim of this study was to evaluate a high-sensitivity troponin T assay performed in three primary health care centres in southeast Sweden and to compare the outcome with a point-of-care troponin T test.METHODS:This study included 115 patients who consulted their general practitioner for chest pain, dyspnoea on exertion, unexplained weakness and/or fatigue in the last 7days. Troponin T was analysed by a point-of-care test and a high-sensitivity method together with N-terminal pro-B-type natriuretic peptide (NT-proBNP) and creatinine. All patients were checked for AMI or unstable angina (UA) within 30days of study enrolment. Univariate and multivariate logistic regression was carried out to examine possible connections between troponin T[greater than or equal to]15ng/L, clinical variables and laboratory findings at baseline. In addition, 21 patients with troponin T[greater than or equal to]15ng/L and no signs of AMI or UA were followed up for 2-3years.RESULTS:Three patients were diagnosed with AMI and three with UA. At the [greater than or equal to]15ng/L cut-off, the troponin T method had 100% sensitivity, 75% specificity for AMI and a positive predictive value of 10%. The troponin T point-of-care test missed one case of AMI and the detection limit was 50ng/L. Troponin T[greater than or equal to]15ng/L was correlated to age [greater than or equal to]65years (odds ratio (OR), 10.9 95% CI 2.28-51.8) and NT-proBNP in accordance with heart failure (OR 8.62 95% CI 1.61-46.1). Fourteen of the 21 patients, without signs of AMI or UA at baseline, still had increased troponin T at follow-up after 2-3years.CONCLUSIONS:A high-sensitivity troponin T assay could become useful in primary care as a point-of-care test for patients <65years. For patients older than 65-70years, a higher decision limit than [greater than or equal to]15ng/L should be considered and used in conjunction with clinical parameters and possibly with NT-proBNP.

Keywords
Primary health care, Acute coronary syndrome, Chest pain, Troponin T, Point-of-care testing
National Category
Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:liu:diva-122874 (URN)10.1186/s13104-015-1174-0 (DOI)26036786 (PubMedID)
Available from: 2015-11-26 Created: 2015-11-26 Last updated: 2017-12-01
Milovanovic, M., Eriksson, K., Winblad, B., Nilsson, S., Lindahl, T., Post, C. & Järemo, P. (2014). Alzheimer and platelets: Low-density platelet populations reveal increased serotonin content in Alzheimer type dementia. Clinical Biochemistry, 47(15), 51-53
Open this publication in new window or tab >>Alzheimer and platelets: Low-density platelet populations reveal increased serotonin content in Alzheimer type dementia
Show others...
2014 (English)In: Clinical Biochemistry, ISSN 0009-9120, E-ISSN 1873-2933, Vol. 47, no 15, p. 51-53Article in journal (Refereed) Published
Abstract [en]

Introduction: Alzheimers disease (AD) is a progressive form of dementia characterized by an increase in the toxic substance beta-amyloid in the brain. Platelets display a substantial heterogeneity with respect to density. They further contain a substantial amount of beta-amyloid precursor protein. Platelets take up and store serotonin (5-HT) that plays an important role in the pathogenesis of severe depression. The current study aims to investigate platelet serotonin content in different platelet density populations. Material and methods: The study involved 8 patients (age 70 +/- 8 (SD) years) (3 females/5 males) with moderate AD. 6 healthy elderly subjects (age 66 +/- 9 (SD) years) (3 females/3 males) served as controls. The platelet population was divided into 17 subpopulations according to density, using a linear Percoll (TM) gradient. Platelets were counted in all fractions. After cell lysis an ELISA technique was employed to determine the 5-HT content in each platelet subfraction. Results: The two study groups did not differ significantly regarding platelet distribution in the gradients, but AD sufferers have a significantly higher 5-HT content (p less than 0.05) in the lighter platelet populations. Discussion: AD-type dementia proved to be associated with lighter platelets containing more 5-HT. It is possible that platelets from AD patients release less 5-HT. It is speculated that AD synapses are affected in a manner comparable to platelets, which could explain why 5-HT reuptake inhibitors are less effective in AD dementia.

Place, publisher, year, edition, pages
Elsevier, 2014
Keywords
Alzheimers disease; Fibrinogen; Platelets; Platelet activity; Platelet density; Platelet heterogeneity; Serotonin
National Category
Basic Medicine Clinical Medicine
Identifiers
urn:nbn:se:liu:diva-111746 (URN)10.1016/j.clinbiochem.2014.07.007 (DOI)000342822100008 ()25041722 (PubMedID)
Note

Funding Agencies|Ahlens Foundation; Gun and Bertil Stohnes Foundation; Magnus Bergvalls Foundation; "Stiftelsen for Gamla Tjanarinnor"; Swedish Alzheimer Foundation; Swedish Board for Health and Welfare; Pfizer AB, Sweden

Available from: 2014-10-31 Created: 2014-10-31 Last updated: 2018-01-11Bibliographically approved
Nilsson, S., Andersson, A., Janzon, M., Karlsson, J.-E. & Levin, L.-Å. (2014). Cost consequences of point-of-care troponin T testing in a Swedish primary health care setting. Scandinavian Journal of Primary Health Care, 32(4), 241-247
Open this publication in new window or tab >>Cost consequences of point-of-care troponin T testing in a Swedish primary health care setting
Show others...
2014 (English)In: Scandinavian Journal of Primary Health Care, ISSN 0281-3432, E-ISSN 1502-7724, Vol. 32, no 4, p. 241-247Article in journal (Refereed) Published
Abstract [en]

Objective. To evaluate the safety and cost-effectiveness of point-of-care troponin T testing (POCT-TnT) for the management of patients with chest pain in primary care. Design. Prospective observational study with follow-up. Setting. Three primary health care (PHC) centres using POCT-TnT and four PHC centres not using POCT-TnT in south-east Sweden. Patients. All patients greater than= 35 years of age, contacting one of the PHC centres for chest pain, dyspnoea on exertion, unexplained weakness and/or fatigue, with no other probable cause than cardiac, were included. Symptoms must have commenced or worsened during the previous seven days. Main outcome measures. Emergency referral rates, diagnoses of acute myocardial infarction (AMI) or unstable angina (UA), and costs were collected for 30 days after the patient sought care at the PHC centre. Results. A total of 196 patients with chest pain were included: 128 in PHC centres with POCT-TnT and 68 in PHC centres without POCT-TnT. Fewer patients from the PHC centres with POCT-TnT (n = 32, 25%) were emergently referred to hospital than from centres without POCT-TnT (n = 29, 43%; p = 0.011). Eight patients (6.2%) from PHC centres with POCT-TnT were diagnosed with AMI or UA compared with six patients (8.8%) from centres without POCT-TnT (p = 0.565). Two patients with AMI or UA were classified as missed cases from PHC centres with POCT-TnT and there were no missed cases from PHC centres without POCT-TnT. SKr290 000 was saved per missed case of AMI or UA. Conclusion. The use of POCT-TnT in primary care may be cost saving but at the expense of missed cases.

Place, publisher, year, edition, pages
Informa Healthcare, 2014
Keywords
Acute myocardial infarction; general practice; point-of-care testing; primary care; Sweden; troponin T; cost
National Category
Basic Medicine Clinical Medicine
Identifiers
urn:nbn:se:liu:diva-113177 (URN)10.3109/02813432.2014.984901 (DOI)000346108700014 ()25434410 (PubMedID)
Note

Funding Agencies|County Council of Ostergotland

Available from: 2015-01-13 Created: 2015-01-12 Last updated: 2018-01-11
Norlund, L., Norlund, P., Nilsson, S., Skov-Poulsen, K., Karlsson, P. & Nordin, G. (2014). Patientnära analyser används inte enhetligt i primärvården. Läkartidningen, 111(24), 1054-1056
Open this publication in new window or tab >>Patientnära analyser används inte enhetligt i primärvården
Show others...
2014 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 111, no 24, p. 1054-1056Article in journal (Refereed) Published
Abstract [sv]

I en enkätstudie har omfattningen av den patientnära laboratorieverksamheten i dagens svenska primärvård kartlagts. De fem vanligaste analyserna var urintestremsa, P-glukos, P-CRP och snabbtest för grupp A-streptokocker samt B-hemoglobin.

Jämfört med data som publicera­des för 20 år sedan har volymen av patientnära analyser ökat, framför allt på grund av den nya analysen CRP.

Även graden av ackreditering och kvalitetssäkring i dagens patientnära laborerande studerades; det framgick att ackrediteringsgraden varierar mellan 0 och 100 procent i olika regioner.

Abstract [en]

Primary health care encompasses laboratory testing where the entire analysis is performed by health care professionals in close proxim­ity to the patient. The purpose of this survey was to understand the range of testing performed in primary health care in Sweden. The results obtained from the survey have been compared to data on the same topic published twenty years ago. The most frequently performed analyses in primary health care have barely changed in the last twenty years. For example, hemoglobin and sedimentation rate analyses are still prevalent. The variety of analyses performed in primary health care has increased, however. C-reactive protein is now a commonly performed analysis. Moreover, in this survey, the degree to which laboratories are quality assured and accredited has been investigated. Accreditation and quality assurance of laboratories varies regionally in Sweden with those facilities meeting the criteria varying from 0% in a province to 100%.

Place, publisher, year, edition, pages
Läkartidningen Förlag AB, 2014
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-108123 (URN)
Available from: 2014-06-25 Created: 2014-06-25 Last updated: 2017-12-05Bibliographically approved
Grönlund, V., Rudenas, A., Appel, M., Ednarsson, T., Nilsson, S., Tingström, P., . . . Kärner Köhler, A. (2014). Problem-based learning after Coronary artery disease - how do patients experience it?. In: : . Paper presented at EuroHeartCare 2014, 4-5 April 2014, Stavanger, Norway. Sage Publications
Open this publication in new window or tab >>Problem-based learning after Coronary artery disease - how do patients experience it?
Show others...
2014 (English)Conference paper, Poster (with or without abstract) (Other academic)
Place, publisher, year, edition, pages
Sage Publications, 2014
Series
European Journal of Cardiovascular Nursing, ISSN 1474-5151 ; 2014:13, Suppl.1
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-107998 (URN)10.1177/1474515114521363 (DOI)
Conference
EuroHeartCare 2014, 4-5 April 2014, Stavanger, Norway
Note

The DOI links to a summary of all Moderated Posters. Se page S41 in PDF file for the publication (P 103).

Available from: 2014-06-25 Created: 2014-06-24 Last updated: 2019-06-27Bibliographically approved
Organisations

Search in DiVA

Show all publications